StonvexLoading…
StonvexStonvexStonvexCore line items from KDK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $3.80M | $14.93M | $16.95M |
Operating Income | $-112.63M | $-61.72M | $-53.85M |
Net Income | $-585.52M | $-69.46M | $-56.95M |
EPS (Diluted) | $-6.42 | $-1.19 | $-0.98 |
Total Assets | $159.41M | $35.56M | $525.45M |
Total Liabilities | $219.27M | $115.75M | $22.78M |
Cash & Equivalents | $50.76M | $16.71M | $27.76M |
Free Cash Flow OCF − CapEx | $-116.47M | $-54.15M | $-47.11M |
Shares Outstanding | 175.44M | 58.06M | 57.93M |